Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland

被引:91
作者
Hryniewicz, K
Szczypa, K
Sulikowska, A
Jankowski, K
Betlejewska, K
Hryniewicz, W
机构
[1] Natl Reference Ctr Antibiot Sera & Vaccines, Cent Res Lab, PL-00725 Warsaw, Poland
[2] Warsaw Univ, Sch Med, Dept Internal Med, Warsaw, Poland
关键词
D O I
10.1093/jac/47.6.773
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Worldwide data show that there is increasing resistance among urinary tract pathogens to conventional drugs. The aim of this study was to obtain data on susceptibility patterns of pathogens responsible for urinary tract infections (UTIs) in Poland to currently used antimicrobial agents. A multicentre study of 141 pathogens from hospital-acquired infections and 460 pathogens from community-acquired infections was carried out between July 1998 and May 1999. The most prevalent aetiological agent was Escherichia coli (73.0%), followed by Proteus spp. (8.9%) and other species of Enterobacteriaceae (9.6%). Few community infections were caused by Gram-positive bacteria (2.2%). Gram-positive cocci were isolated more frequently from a hospital setting (14.1%) and the most common were Enterococcus spp. (8.5%). Pseudomonas aeruginosa was found only among hospital isolates and was responsible for 10.7% of infections. E. coli isolates from both community and hospital infections were highly susceptible to many antimicrobial agents with the exception of those isolates producing extended spectrum beta -lactamases (ESBLs). Of all Enterobacteriaceae tested, 38 strains (6.9%) were capable of producing ESBLs.
引用
收藏
页码:773 / 780
页数:8
相关论文
共 26 条
  • [1] Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in eight hospitals in Turkey
    Aksaray, S
    Dokuzoguz, B
    Güvener, E
    Yücesoy, M
    Yulug, N
    Kocagöz, S
    Ünal, S
    Çetin, S
    Calangu, S
    Günaydin, M
    Leblebicioglu, H
    Esen, S
    Bayar, B
    Willke, A
    Findik, D
    Tuncer, I
    Baysal, B
    Günseren, F
    Mamikoglu, L
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (05) : 695 - 699
  • [2] A MULTICENTER STUDY OF THE IN-VITRO ACTIVITY OF CEFOTAXIME, CEFUROXIME, CEFTAZIDIME, OFLOXACIN AND CIPROFLOXACIN AGAINST BLOOD AND URINARY PATHOGENS
    AMYES, SGB
    BAIRD, DR
    CROOK, DW
    GILLESPIE, SH
    HOWARD, AJ
    OPPENHIEM, BA
    PEDLER, SJ
    PAULL, A
    TOMPKINS, DS
    LAWRIE, SA
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (05) : 639 - 648
  • [3] In-vitro activity of cefepime and seven other antimicrobial agents against 1518 non-fermentative Gram-negative bacilli collected from 48 Canadian health care facilities
    Blondeau, JM
    Laskowski, R
    Borsos, S
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (04) : 545 - 548
  • [4] CLARRIDGE JE, 1998, CUMITECH B, V2
  • [5] Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection
    Cormican, M
    Morris, D
    Corbett-Feeeney, G
    Flynn, J
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 32 (04) : 317 - 319
  • [6] SUSCEPTIBILITY OF URINARY PATHOGENS IN A DUBLIN TEACHING HOSPITAL
    CUNNEY, RJ
    MCNALLY, RM
    MCNAMARA, EM
    ALANSARI, N
    SMYTH, EG
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 1992, 161 (11) : 623 - 625
  • [7] CLINICAL AND BACTERIOLOGICAL EFFECTS OF THERAPY OF URINARY-TRACT INFECTION IN PRIMARY HEALTH-CARE - RELATION TO INVITRO SENSITIVITY TESTING
    FERRY, S
    BURMAN, LG
    HOLM, SE
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1988, 20 (05) : 535 - 544
  • [8] Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997
    Fluit, AC
    Jones, ME
    Schmitz, FJ
    Acar, J
    Gupta, R
    Verhoef, J
    [J]. ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY, 2000, 77 (02): : 147 - 152
  • [9] Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY Antimicrobial Surveillance Program (1998)
    Gales, AC
    Jones, RN
    Gordon, KA
    Sader, HS
    Wilke, WW
    Beach, ML
    Pfaller, MA
    Doern, GV
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (03) : 295 - 303
  • [10] In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: A Spanish multicenter study
    Garcia-Rodriguez, JA
    Martin, IT
    Baquero, F
    Cisterna, R
    Gobernado, M
    Linares, F
    Martin-Luengo, F
    Piedrola, G
    [J]. JOURNAL OF CHEMOTHERAPY, 1997, 9 (06) : 394 - 402